Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Crippa

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Anticancer Research|May 5, 1999
The breast cancer cell line MCF7 as a model of 99mTc-SestaMIBI, 99mTc-tetrofosmin and 99mTc-Medronate incorporationS N Molteni, E Seregni, C Botti, et al.
Tumori|January 5, 2002
Nuclear medicine advances in breast cancer imagingE Bombardieri, F Crippa, S M Baio, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1994
Thymidine kinase (TK) activity as a prognostic parameter of survival in lymphoma patientsA Bogni, A Cortinois, G Grasselli, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1986
New anthracycline analogs in advanced breast cancerV Bonfante, L Ferrari, C Brambilla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1991
Activity and toxicity of 4'-iodo-4'-deoxydoxorubicin in patients with advanced breast cancerL Gianni, G Capri, M Greco, et al.
The International Journal of Biological Markers|January 1, 1991
Preliminary study on serum levels of mucinous like cancer antigen (MCA) in patients with breast disease: comparison with CEAF Boccardo, E Bombardieri, S Zanardi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 20, 2000
Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanomaF Crippa, M Leutner, F Belli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: clinical results in patients with minimal residual disease of ovarian cancerF Crippa, G Bolis, E Seregni, et al.
La Radiologia Medica|November 1, 1988
[Usefulness of gallium 67 in research into the need for radical cervical lymph node dissection in patients with head and neck carcinomas]S Basso Ricci, A Rodari, R Molinari, et al.
International Journal of Oncology|May 11, 2011
Preliminary-results of preoperative axillary radioimmunoscintigraphy with in-111 b72.3 in breast-cancerF Crippa, R Agresti, E Bombardieri, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Anticancer Research|May 5, 1999
The breast cancer cell line MCF7 as a model of 99mTc-SestaMIBI, 99mTc-tetrofosmin and 99mTc-Medronate incorporationS N Molteni, E Seregni, C Botti, et al.
Tumori|January 5, 2002
Nuclear medicine advances in breast cancer imagingE Bombardieri, F Crippa, S M Baio, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1994
Thymidine kinase (TK) activity as a prognostic parameter of survival in lymphoma patientsA Bogni, A Cortinois, G Grasselli, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1986
New anthracycline analogs in advanced breast cancerV Bonfante, L Ferrari, C Brambilla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1991
Activity and toxicity of 4'-iodo-4'-deoxydoxorubicin in patients with advanced breast cancerL Gianni, G Capri, M Greco, et al.
The International Journal of Biological Markers|January 1, 1991
Preliminary study on serum levels of mucinous like cancer antigen (MCA) in patients with breast disease: comparison with CEAF Boccardo, E Bombardieri, S Zanardi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 20, 2000
Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanomaF Crippa, M Leutner, F Belli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: clinical results in patients with minimal residual disease of ovarian cancerF Crippa, G Bolis, E Seregni, et al.
La Radiologia Medica|November 1, 1988
[Usefulness of gallium 67 in research into the need for radical cervical lymph node dissection in patients with head and neck carcinomas]S Basso Ricci, A Rodari, R Molinari, et al.
International Journal of Oncology|May 11, 2011
Preliminary-results of preoperative axillary radioimmunoscintigraphy with in-111 b72.3 in breast-cancerF Crippa, R Agresti, E Bombardieri, et al.
Pageof 7